我们的网站为什么显示成这样？

可能因为您的浏览器不支持样式，您可以更新您的浏览器到最新版本，以获取对此功能的支持，访问下面的网站，获取关于浏览器的信息：

|本期目录/Table of Contents|

功能性三尖瓣关闭不全的介入治疗研究现状和进展

《心脏杂志》[ISSN:1009-7236/CN:61-1268/R]

期数:
2015年第3期
页码:
368-370
栏目:
综述
出版日期:
2015-01-11

文章信息/Info

Title:
Status and progress of treatment for tricuspid valve insufficiency
作者:
宗刚军; 姜海滨
（解放军第101医院心内科，江苏 无锡 214044）
Author(s):
ZONG Gang-jun;  JIANG Hai-bin
(Department of Cardiology, PLA 101 Hospital, Wuxi 214044, Jiangsu, China)
关键词:
三尖瓣关闭不全; 介入治疗; 瓣膜修复; 瓣膜支架
Keywords:
tricuspid insufficiency;  interventional therapy;  valve repair;  valved stent
分类号:
R542
DOI:
-
文献标识码:
A
摘要:
三尖瓣关闭不全在临床上比较常见。外科手术治疗三尖瓣关闭不全存在诸多局限性，而三尖瓣关闭不全的介入治疗技术仍处于动物实验阶段，现在还没有一种治疗手段被认为是最理想的方法。微创瓣膜修复技术以及腔静脉瓣膜支架植入方法的研究，有望使三尖瓣膜关闭不全的治疗方法出现一次革命。
Abstract:
Tricuspid regurgitation is a most common clinical problem. Surgical treatment of tricuspid insufficiency has many limitations and interventional treatment of tricuspid insufficiency is still in the stage of animal experiments. No method has currently been acclaimed as the best method. Minimally invasive surgical valve repair technology and venous valved stent implantation are expected to bring about a revolution in the treatment of tricuspid insufficiency.

参考文献/References

[1]Taramasso M,Vanermen H,Maisano F,et al.The growing clinical importance of secondary tricuspid regurgitation[J].J Am Coll Cardiol,2012,59(8):703-710.
[2]Lee JW,Song JM,Park JP,et al.Long-Term prognosis of isolated significant tricuspid regurgitation[J].Circ J,2010,74(2):375-380.
[3]Yilmaz O,Suri RM,Dearani JA,et al.Functional tricuspid regurgitation at the time of mitral valve repair for degenerative leaflet prolapse: The case for a selective approach[J].J Thorac Cardiovasc Surg,2011,142(3):608-613.
[4]Vahanian A,Baumgartner H,Bax J,et al.Guidelines on the management of valvular heart disease:The Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology[J].Eur Heart J,2007,28(2):230-268.
[5]Boudjemline Y,Agnoletti G,Bonnet D,et al.Steps toward the percutaneous replacement of atrioventricular valves an experimental study[J].J Am Coll Cardiol,2005,46(2):360-365.
[6]Bai Y,Zong GJ,Wang HR,et al.An integrated pericardial valved stent special for percutaneous tricuspid implantation: an animal feasibility study[J].J Surg Res,2010,160(2):215-221.
[7]Lauten A,Figulla HR,Willich C,et al.Percutaneous caval stent valve implantation: investigation of an interventional approach for treatment of tricuspid regurgitation[J].Eur Heart J,2010,31(10):1274-1281.
[8]Kaye DM,Byrne M,Alferness C,et al.Feasibility and short-term efficacy of percutaneous mitral annular reduction for the therapy of heart failure-induced mitral regurgitation[J].Circulation,2003,108(15):1795-1797.
[9]St Goar FG,Fann JI,Komtebedde J,et al.Endovascular edge-to-edge mitral valve repair - Short-term results in a porcine model[J].Circulation,2003,108(16):1990-1993.
[10]Minale C,Lambertz H,Nikol S,et al.Selective annuloplasty of the tricuspid valve[J].Two-year experience.J Thorac Cardiovasc Surg,2000,99(5):846-851.
[11]石 践,邓玉普,李学文,等.风湿性心脏病二尖瓣成形中功能性三尖瓣反流的外科治疗[J].中国胸心血管外科临床杂志,1999,6(4):266-267.
[12]Castedo E,Ca?as A,Cabo RA,et al.Edge-to-Edge tricuspid repair for redeveloped valve incompetence after DeVega’s annuloplasty[J].Ann Thorac Surg,2003,75(2):605-606.
[13]Nurozler F,Kutlu T,Kucuk G.Association of edge-to-edge repair to de vega annuloplasty for tricuspid incompetence[J].Scand Cardiovasc J,2007,41(3):192-196.
[14]Ginns J,Ammash N,Bernier PL.The tricuspid valve in adult congenital heart disease[J].Heart Fail Clin,2014,10(1):131-153.
[15]Rogers JH,Bolling SF.Surgical approach to functional tricuspid regurgitation: should we be more aggressive?[J].Curr Opin Cardiol,2014,29(2):133-139.

备注/Memo

备注/Memo:
收稿日期：2014-05-04.
基金项目：国家自然科学基金项目资助（81371657）
通讯作者：宗刚军，副主任医师，主要从事瓣膜病介入治疗基础与临床研究Email:zonggj@163.com
更新日期/Last Update: 2015-02-03